Target intelligence / Profile preview

Luminal proteins and toxins

Molecular classification
Other
01

Overview

Luminal proteins and toxins refer to a diverse group of substances found within the gastrointestinal tract that contribute to various disease states through local irritation or systemic absorption. This category encompasses bacterial toxins (such as Clostridioides difficile toxins A and B), dietary antigens (such as gluten), and metabolic waste products (such as uremic toxins and bile acids). These substances are targeted by non-absorbed therapeutic agents, primarily oral adsorbents and sequestrants, which act by physically binding or sequestering these molecules to prevent their pathological effects. For example, drugs like sevelamer and AST-120 are used to manage hyperphosphatemia and uremia by binding phosphate and uremic toxins, respectively, while others like cholestyramine can neutralize bacterial toxins. Because these agents remain in the gut lumen and are not absorbed into the bloodstream, they offer a unique therapeutic approach but may also lead to non-specific binding of nutrients and other medications.

Other names
Gastrointestinal luminal toxinsIntestinal antigensGut-derived toxinsLuminal substancesEnterosorbents
02

Mechanism of action

Adsorption, sequestration, or enzymatic degradation of proteins and toxins within the gastrointestinal lumen.

03

Biological functions

Immune responseInfectionMetabolismOther
04

Disease associations

InfectionInflammationOther
05

Safety considerations

Non-specific binding of essential nutrientsInterference with co-administered drug absorptionGastrointestinal distressMalabsorption of fat-soluble vitamins
06

Interacting drugs

AST-120 (Kremezin)

6 more in the full profile.

07

Biomarkers

Indoxyl sulfateSerum phosphateClostridioides difficile toxin levelsGluten-derived peptides

Beyond the preview

Go deeper on Luminal proteins and toxins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Luminal proteins and toxins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call